FDA Adverse Event Injury Summary report: N

HAKIM PROGRAMMABLE VALVE WITH PRECHAMBER

MDR report key: 3241275 · Received July 22, 2013

Report

Report Number
1226348-2013-21815
Event Type
Injury
Date Received
July 22, 2013
Date of Event
May 5, 2013
Manufacturer
CODMAN & SHURTLEFF, INC.
Product Code
JXG
PMA / PMN Number
PK974739
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

UPON THE COMPLETION OF THE INVESTIGATION, A FOLLOW UP REPORT WILL BE FILED.

Additional Manufacturer Narrative · 1

UPON COMPLETION OF THE INVESTIGATION IT WAS NOTED THAT THE DEVICE RETURNED WAS 82-3100 AND NOT THAT OF 82-3110 AS INITIALLY REPORTED. IT WAS ALSO FOUND THAT THE STATOR WAS DISLODGED. THEREFORE THE CAM POSITION/PRESSURE COULD NOT BE DETERMINED. UPON FURTHER EXAMINATION IT WAS ALSO FOUND THAT THE VALVE WAS CRACKED AND A BUMP MARK WAS FOUND IN THE VALVE CASING. IN ADDITION, THE CAM MECHANISM WAS ALSO DAMAGED. ALTHOUGH THE EXACT ROOT CAUSE OF THE PROBLEM FOUND WITH THE DEVICE COULD NOT BE DETERMINED IT MIGHT BE POSSIBLE THAT THE DEVICE WAS SUSTAINED TO SOME FORM OF IMPACT. THIS HOWEVER COULD NOT BE DETERMINED. A REVIEW OF THE HISTORY DEVICE RECORDS CONFIRMED THAT THE VALVE CONFORMED TO THE REQUIRED SPECIFICATIONS PRIOR TO DISTRIBUTION. BASED ON THE RESULTS OF THIS INVESTIGATION NO FURTHER ACTION IS REQUIRED. TRENDS WILL BE MONITORED FOR THIS AND SIMILAR COMPLAINTS. AT THE PRESENT TIME THIS COMPLAINT IS CLOSED.

Description of Event or Problem · 1

THE AFFILIATE REPORTED THAT THERE WERE MULTIPLE FAILURES TO REPROGRAM THE VALVE AND THERE WERE CLEAR CLINICAL SIGNS OF DYSFUNCTION. AS A RESULT, THE VALVE WAS REMOVED. UPON REMOVAL, IT WAS NOTICED THAT THE WHEEL OF THE VALVE MECHANISM HAD BEEN DISLOCATED AND RESIDED IN THE SILICONE CHAMBER, PARTLY OBSTRUCTING THE CHAMBER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
340650 HAKIM PROGRAMMABLE VALVE WITH PRECHAMBER SHUNT, CENTRAL NERVOUS SYSTEM & COMPS JXG CODMAN & SHURTLEFF, INC. P.863

Patients

Seq Age Sex Outcome Treatment
1 16 YR Required Intervention